This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
Michael Lahn, Stephan Herbertz, J. Scott Sawyer, Anja J Stauber, Ivelina Gueorguieva, Kyla E Driscoll, Shawn T Estrem, Ann L Cleverly, Durisala Desaiah, Susan C Guba, Karim A Benhadji, Christopher A Slapak
Drug Design Development and Therapy, August 2015, Dove Medical Press
The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.